Kardigan, Inc. (KARD)
Kardigan will go public soon. The estimated IPO date is June 18, 2026.
IPO Price Range
$14.00 - $16.00
Shares Offered
23,333,334
Deal Size
$350.00M
Company Description
Kardigan is a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist.
Our mission is to develop multiple targeted cardiovascular treatments in parallel that bring people with cardiovascular diseases closer to the cures they deserve.
We leverage deep domain expertise in cardiovascular biology, patient data, and advanced analytics to accelerate drug discovery and development, aiming to deliver impactful therapies efficiently and at scale.
We are advancing three late-stage cardiovascular therapies in indications for which no approved therapies currently exist.
Kardigan, Inc.
| Country | United States |
| Founded | 2023 |
| IPO Date | Jun 18, 2026 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 241 |
| CEO | Tassos Gianakakos |
Contact Details
Address: 506 Carnegie Center Drive, Suite 201 Princeton, NJ 08540 United States | |
| Phone | (415) 573-3220 |
| Website | kardigan.bio |
Stock Details
| Ticker Symbol | KARD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 2123613 |
| Employer ID | 93-2994203 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Tassos Gianakakos | Chief Executive Officer, Director, and Chair |
| Brianne Puglisi | Chief Financial Officer |
| Jay Edelberg | Chief Medical Officer |
| Andy Pasternak | Chief Strategy Officer |
| John B. Moriarty, Jr. | Chief Legal Officer and Corporate Secretary |
| Paul Berns | Director |
| Douglas Giordano | Director |
| David Meeker, M.D. | Director |
| Kim Popovits | Director |
| Tim Walbert | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 17, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jun 17, 2026 | CERT | Certification by an exchange approving securities for listing |
| Jun 17, 2026 | S-1MEF | Registration adding securities to prior Form S-1 registration |
| Jun 15, 2026 | 8-A12B | Registration of securities |
| Jun 11, 2026 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| May 26, 2026 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| May 4, 2026 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Mar 26, 2026 | DRS | [Cover] Draft Registration Statement |